Login
$IDYA
$30.36 +$0.00 (0.0%) After hours

$IDYA SEC Filings

Filed On Filing
03 Nov 2026 S-8
03 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition

Data presented at ESMO 2026 collectively supports the potential of darovasertib to become a foundational new therapy across the treatment journey of uveal melanoma in both primary and metastatic disease, irrespective of HLA-A*02:01 allel...

08 Oct 2026 Form 4: Hata Yujiro S, Director

Received 26,338 shares by exercise or conversion ($114K) · Sold 26,338 shares ($985K)

06 Oct 2026 144
14 Aug 2026 SCHEDULE 13G
04 Aug 2026 10-Q
04 Aug 2026 8-K: Results of Operations and Financial Condition

Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing is underway under the real-time oncology review program (RTOR) with completion...

31 Jul 2026 SCHEDULE 13G
09 Jul 2026 Form 4: Ruiz Briseno Andres, Chief Accounting Officer

Received 9,550 shares by exercise or conversion ($123K) · Sold 9,550 shares ($382K)

07 Jul 2026 144
23 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders; Other Events

On June 16, 2026, IDEAYA Biosciences, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in mor...

18 Jun 2026 Form 4: Yarno Wendy L, Director

Granted 20,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Stein Jeffrey, Director

Granted 20,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Rosen Terry J, Director

Granted 20,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Morrison Scott W, Director

Granted 20,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Mackey Catherine J, Director

Granted 20,000 Stock Option (right to buy)

18 Jun 2026 Form 4: Hampton Malcolm Garret, Director

Granted 20,000 Stock Option (right to buy)

10 Jun 2026 8-K: Other Events

Pre-Funded Warrants to Purchase 5,555,576 Shares of Common Stock

09 Jun 2026 424B5

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support